(Press-News.org) A cellular signal essential to the development of the skeleton increases during aging to weaken bones, finds a new study in mice.
The study, led by researchers from NYU Grossman School of Medicine, found that blocking the signaling pathway, called Notch, in aging skeletal stem cells caused a “massive increase” in bone mass and restored lost bone-healing ability during aging.
The study results revolve around immature stem cells, which have the capacity to mature into more than one cell type. Bone is among the tissues that keep pools of stem cells on hand into adulthood, ready to mature into replacement cells that maintain healthy tissue and repair broken bones.
Skeletal stem and progenitors cells, or SSCPs, in the bone marrow have the capacity to become either new bone-making cells called osteoblasts or fat-making cells called adipocytes, the researchers say. Past studies have shown that such cells are more likely to become cells that make fat than bone as skeletal tissues age, making bone more vulnerable to fracture. The cellular signals involved, however, had been unclear going into the current work.
Published online September 27 in Bone Research, a Nature journal, the new work, by looking closely at the genes expressed in SSCPs of mice as they aged, found the Notch pathway to become abnormally active, shifting the cells toward the fate that increases fatty degeneration of bone marrow. When the authors genetically engineered mice to lack Nicastrin, a core part of the Notch signaling chain reaction, it returned the stem cells to the bone-making cell pathway, and increased bone formation “even beyond that seen in young mice.”
Notch signaling, woven as it is into so many cellular pathways, is not a good target for drug therapy, but the study authors pinpointed a protein called Ebf3 that carries the Notch signal forward, and which could be targeted by drugs.
“Our findings reveal that Notch in skeletal stem cells becomes abnormal with age, and that blocking it prevents age-related skeletal degeneration,” says corresponding study author Philipp Leucht, MD, PhD, the Raj-Sobti-Menon Associate Professor in the Department of Orthopedic Surgery and Cell Biology at NYU Langone Health. “The reprogramming of adult stem cells as a source of bone-making cells in healing-compromised people has profound therapeutic potential, and we hope to confirm the value in future studies of Ebf3 as a drug target in preventing osteoporosis.”
Aging is known to come with loss of the ability of stem cells to become bone-making cells, with related skeletal deterioration among the most common causes of age-associated impairment. To date, there are no therapeutics to rescue or maintain the bone-making function in aging SSPCs, say the authors. As such, they say it is an imperative to clarify the mechanisms that trigger the bone-to-fat shift in the skeleton to prolong healthy lifespans.
To address this challenge, the research team used a technique called single-cell RNA sequencing of young and aged mouse bones to reveal that Notch signaling becomes elevated in SSPCs during aging. Genetic information is captured in the molecular “letters” of DNA chains, which are converted into RNA snippets on the way to becoming proteins that make up cell signals and structures. Sequencing technologies reveal the order of the genetic letters in healthy function, and the changes linked to diseases, with a newer capability being to look at genetic activity based on RNA profiles in single cells. This provided the research team with a closer view of cellular differences in SSPCs as they aged.
Notch signaling is important to the development of many tissues in the womb, but then is suppressed to enable healthy adult tissue function, Leucht adds. Diseases like cancer, and the aging process, are linked to the abnormal re-activation of developmental processes, where the genetic systems (heterochromatin) that block access to certain genes break down. Thus, the current study’s finding that Notch-related genes were abnormally upregulated could reveal disease mechanisms behind forms of deterioration seen in other tissues and organs.
"As a rising trainee in orthopedic surgery, I am intrigued by the molecular and cellular machinery that governs skeletal stem cell fate," says first author Lindsey Remark, MD, PhD, a graduate student in the Leucht laboratory. "Our newly gained knowledge opens potential therapeutic avenues to overcome age-related bone loss by manipulating down-stream effectors for Notch signaling in these stem cells."
Along with Leucht and Remark, study authors from the Department of Orthopedic Surgery were Kevin Leclerc, Malissa Ramsukh, Sooyeon Lee, Lauren Gillinov, Paulo El Parente, Margaux Sambon, Pablo Atria, Alesha Castillo, and Sophie Morgani. Also NYU authors were Ziyan Lin and Aristotelis Tsirigos in the Applied Bioinformatics Laboratories; Mohamed Ali and Christopher Park in the Department of Pathology; and Vasudev Nayak and Lukasz Witek in the Department of Molecular Pathobiology at the New York University College of Dentistry. Also study authors were Backialakshmi Dharmalingam and Ralf Adams at the Max Planck Institute for Molecular Biomedicine and the Department of Tissue Morphogenesis at the University of Münster in Germany.
This work was supported by National Institutes of Health grants K08AR069099, R01AG056169, F30AG072834, S10OD010751, 5P30CA016087, and P41 EB017183, as well as by the Laura and Isaac Perlmutter Cancer Center grant P30CA016087, the Patricia and Frank Zarb Family, and the New York Stem Cell Foundation.
Blocking abnormal stem cell signal during aging lessens related bone loss
ELSE PRESS RELEASES FROM THIS DATE:
Henry Ford Health first in Michigan to introduce advanced prostate diagnostic technology
DETROIT (Sept. 27, 2023) – Henry Ford Health is the first health system in Michigan to offer ExactVu, a cutting-edge technology for diagnosing and evaluating prostate cancer. Enhancing the precision and speed of diagnosis, this new technology ensures patients receive timely and appropriate care, while also providing a more efficient and convenient experience than other diagnostic methods. "Throughout the years, advancements in prostate cancer diagnostic and treatment modalities have made a tremendous difference for patients,” said Craig Rogers, M.D., Chair of the Department of Urology at Henry Ford Cancer. “This is ...
Resolving a seeming contradiction, study advances understanding of visual recognition memory
Because figuring out what is new and what is familiar in what we see is such a critically important ability for prioritizing our attention, neuroscientists have spent decades trying to figure out how our brains are typically so good at it. Along the way they’ve made key observations that seem outright contradictory, but a new study shows that the mystifying measures are really two sides of the same coin, paving the way for a long-sought understanding of “visual recognition memory” (VRM). VRM is the ability to quickly recognize the familiar things in scenes, which can then be de-prioritized so that we can focus on the new things that might be more important ...
The Buck Institute and Phenome Health announce major strategic partnership
The Buck Institute for Research on Aging and Phenome Health are joining forces in the quest to understand the biology of aging. Phenome Health, a Seattle-based nonprofit research organization led by CEO Lee Hood, MD, PhD, uses a data-driven approach to health and disease that integrates diverse types of biological big data. The new Center for Phenomic Health at the Buck will be co-led by Dr. Hood, who joins the Buck as Chief Innovation Officer and Distinguished Professor, and Eric Verdin, MD, Buck President ...
Revolutionary breakthrough: human stomach micro-physiological system unveiled
A groundbreaking development in biomedical engineering has led to the creation of a human stomach micro-physiological system (hsMPS), representing a significant leap forward in understanding and treating various gastrointestinal diseases, including stomach cancer. The research team, led by Professor Tae-Eun Park from the Department of Biomedical Engineering at UNIST and Professor Seong-Ho Kong from Seoul National University Hospital, has successfully developed a biomimetic chip that combines organoid and organ-on-a-chip technologies to simulate the complex defense mechanisms of the human gastric mucosa. Organoids, which mimic human organs using stem cells, have ...
ORNL launches Center for AI Security Research to study AI’s impacts on society, security
The Department of Energy’s Oak Ridge National Laboratory announced the establishment of its Center for AI Security Research, or CAISER, to address threats already present as governments and industries around the world adopt artificial intelligence and take advantage of the benefits it promises in data processing, operational efficiencies and decision-making. In partnership with federal agencies such as the Air Force Research Laboratory’s Information Directorate and the Department of Homeland Security (DHS) Science and Technology Directorate ...
Extreme weight loss: Star sheds unexpected amounts of mass just before going supernova
Cambridge, Mass. — A newly discovered nearby supernova whose star ejected up to a full solar mass of material in the year prior to its explosion is challenging the standard theory of stellar evolution. The new observations are giving astronomers insight into what happens in the final year prior to a star’s death and explosion. SN 2023ixf is a new Type II supernova discovered in May 2023 by amateur astronomer Kōichi Itagaki of Yamagata, Japan shortly after its progenitor, or origin star, ...
Target: BP™ intitiative helps more than 8.6 million Americans with hypertension improve heart health
DALLAS, September 27, 2023 — The American Heart Association and American Medical Association (AMA) nationally recognized 1,709 health care organizations (HCOs) — 400 more than in 2022 — for their efforts to prioritize control of their patients’ blood pressure (BP), a leading preventable risk factor for heart disease, stroke and premature death. According to the 2022 American Heart Association Statistical Update, nearly half of U.S. adults — 121.5 million ...
Tiny CRISPR tool could help shred viruses
HOUSTON – (Sept. 27, 2023) Small and precise: These are the ideal characteristics for CRISPR systems, the Nobel-prize winning technology used to edit nucleic acids like RNA and DNA. Rice University scientists have described in detail the three-dimensional structure of one of the smallest known CRISPR-Cas13 systems used to shred or modify RNA and employed their findings to further engineer the tool to improve its precision. According to a study published in Nature Communications, the molecule works differently than other proteins in the same family. “There are different types of CRISPR systems, and the one ...
Plastic cloud: New study analyzes airborne microplastics in clouds
Plastic particles less than 5 mm in size are called “microplastics.” These tiny bits of plastic are often found in industrial effluents, or form from the degradation of bulkier plastic waste. Research shows that large amounts of microplastics are ingested or inhaled by humans and animals alike and have been detected in multiple organs such as lung, heart, blood, placenta, and feces. Ten million tons of these plastic bits end up in the ocean, released with the ocean spray, and find their way into the atmosphere. This implies that microplastics may have become an essential component of clouds, ...
Winners of the ASTRO-Sumitomo Pharma-Pfizer Alliance new combination therapy challenge announced
ARLINGTON, Va., September 27, 2023 — The American Society for Radiation Oncology (ASTRO) today announced the three winning research proposals for the 2022 ASTRO-Myovant Sciences (now known as Sumitomo Pharma)-Pfizer Alliance New Combination (Relugolix-Radiation) Therapy Challenge. The Challenge aims to identify research that addresses ways prostate cancer treatments can be improved with the gonadotropin-releasing hormone (GnRH) receptor antagonist relugolix in patients who received radiation therapy. The Challenge invited researchers to propose the study of relugolix in different scenarios: ...